Mentions in press and media 5
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Aug 31, 2026 | BMJ report highlights CTE in deceased NFL players (2016-2021) - at least one in four | Reported incidence of CTE found necessitates living diagnoses, not just for professional athletes, but for others where repetitive brain injuries occur. Clinicians cannot effectively diagnose, monitor, or treat a disease that can currently ... |
| Jun 28, 2023 | CereMark Pharma and Invicro to Collaborate on Development of F-18 Flornaptitril | CereMark Prepares for Pivotal Phase 3 Clinical Trial for Prediction of Cognitive Decline in Alzheimer’s Disease, CTE and Other Neurodegenerative Diseases NEW YORK, NEW YORK, USA, June 28, 2023/EINPresswire.com/ -- CereMark Pharma LLC (“Cere... |
| May 3, 2023 | CereMark Announces Supply Agreement with SpectronRx for Production of F-18 Flornaptitril For Phase 3 Clinical Trials | Phase 3 Clinicals To Evaluate Prediction of Cognitive Decline in Alzheimer’s Disease, Chronic Traumatic Encephalopathy and Other Neurodegenerative Diseases NEW YORK , NEW YORK , USA, May 3, 2023/EINPresswire.com/ -- CereMark Pharma LLC (“Ce... |
| Aug 2, 2022 | Imaging Agent of Alzheimer’s Disease, Chronic Traumatic Encephalopathy and Other Neurodegenerative Diseases | CereMark Pharma to Commence Phase 3 FDA Clinical Study LOS ANGELES, CALIFORNIA, UNITED STATES, August 2, 2022 /EINPresswire.com/ -- CereMark Pharma LLC (“CereMark”) today announced that additional patents have been awarded to the University... |
Reviews 0
FAQ about CereMark Pharma LLC
What has the press written about CereMark Pharma LLC?
Parsers VC has collected 5 articles mentioning CereMark Pharma LLC, among them “BMJ report highlights CTE in deceased NFL players (2016-2021) - at least one in four” (Aug 31, 2026) and “CereMark Pharma and Invicro to Collaborate on Development of F-18 Flornaptitril” (Jun 28, 2023).
Is CereMark Pharma LLC still active?
Yes, CereMark Pharma LLC is active; its latest activity on Parsers VC dates from Sep 23, 2026.